Clinical Trial Update: NAION Treatment With Oral Prednisolone and Erythropoietin Injection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating oral prednisolone and erythropoietin for non-arteritic anterior ischemic optic neuropathy (NAION).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-arteritic Anterior Ischemic Optic Neuropathy

Drugs mentioned

• Erythropoietin (erythropoietin)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) | Phase 2 | Status: UNKNOWN